Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy

Neuroimmunology and Multiple Sclerosis

The clinical research portfolio includes studies in multiple sclerosis and related neurological immune-mediated conditions, with attention to symptom control and disease activity.

  • Multiple sclerosis
  • Covid fog and post-COVID-19 neurological symptoms
  • Neuropsychological and psychiatric assessment

Research activity also extends to post-infectious cognitive and functional impairment, including evaluation of neurological, ENT, and laboratory correlates.

Autoimmune Vasculitis and Large-Vessel Inflammation

The sponsor funds trials in systemic autoimmune disease, especially ANCA-associated vasculitis and giant cell arteritis, with emphasis on remission maintenance and inflammatory control.

  • ANCA-associated vasculitis
  • Giant cell arteritis
  • Rituximab, cyclophosphamide, etanercept, and methotrexate

These studies reflect interest in treatment strategies for severe vasculitic disease and immune-mediated vascular injury.

Inflammatory Bowel Disease

Clinical work in gastroenterology focuses on refractory Crohn’s disease and ulcerative colitis, particularly in patients who have not responded adequately to prior biologic therapy.

  • Crohn’s disease
  • Ulcerative colitis
  • Biologic therapy and small-molecule therapy

The research landscape includes immune-targeted approaches aimed at controlling intestinal inflammation and achieving steroid-free remission.

Cardiovascular and Acute Coronary Syndrome

The sponsor is active in cardiovascular research centered on acute coronary syndrome and outcomes after percutaneous coronary angioplasty.

  • Acute coronary syndrome
  • Coronary revascularization
  • Metabolic adjunctive therapy

This area includes interest in reducing recurrent ischemic events and improving recovery after coronary intervention.

Pulmonary Infection and Renal Metabolic Complications

Additional studies address pulmonary infections, respiratory compromise, and metabolic complications in nephrotic syndrome, reflecting broader internal medicine interests.

  • COVID-19 and other pulmonary parenchymal infections
  • Respiratory failure
  • Protein-energy wasting in nephrotic syndrome

Research also includes supportive metabolic interventions aimed at preserving nutritional status in severe kidney disease.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Effectiveness of Ketoanalogues in Preventing Muscle Loss in Patients with Nephrotic Syndrome

    Recruiting

    3 1 1 1
    Investigated diseases:
    Poland
  • Title: Study of tianeptine effectiveness in treating cognitive symptoms (brain fog) in patients who have recovered from COVID-19

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Poland
  • Study on the Effectiveness of Infliximab, Ustekinumab, and Vedolizumab for Patients with Resistant Crohn’s Disease

    Recruiting

    2 1 1 1
    Investigated diseases:
    Poland
  • Study on the Effectiveness of Infliximab, Tofacitinib, and Vedolizumab in Patients with Ulcerative Colitis Resistant to Initial Treatment

    Recruiting

    2 1 1 1
    Poland
  • Study on the Effectiveness of Etanercept and Methotrexate for Patients with Giant Cell Arteritis

    Recruiting

    2 1 1 1 1
    Investigated diseases:
    Poland
  • Study of Lactobacillales and Lacidofil in Multiple Sclerosis Patients: Comparing Effectiveness of Probiotic Therapy

    Not yet recruiting

    2 1 1 1
    Poland